Few advancements in contemporary medicine have sparked as much enthusiasm and potential as CAR T-cell therapy.
Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.
Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback